Further, the non-leukemic CD8+ and CD4+ T cell repertoires in T-LGLL were more mature, cytotoxic, and clonally restricted than in other cancers, in RA, and in healthy controls, suggesting the strong immune-editing capacity of a driving antigen. The gene discussed is CD8A; the disease is rheumatoid arthritis.